South China Journal of Preventive Medicine ›› 2025, Vol. 51 ›› Issue (3): 283-287.doi: 10.12183/j.scjpm.2025.0283

• Original Article • Previous Articles     Next Articles

Current status blood pressure control and medication use among community hypertension patients

LIAO Mengfan1, ZHONG Liling1, XU Yan2, ZHANG Yexiang2, LIU Ying1, TAN Haojie3, ZHANG Fangwen3, CHEN Qingsong1,4,5, LIU Xudong1   

  1. 1. School of Public Health, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510310, China;
    2. Guangdong ADR Monitoring Center;
    3. Jun'an Community Health Service Center, Shunde District;
    4. Guangdong Provincial Engineering Technology Research Center for Public Health Detection and Evaluation;
    5. National Medical Products Administration Key Laboratory of Pharmacovigilance Technology and Evaluation
  • Received:2024-08-08 Online:2025-04-21 Published:2025-04-21

Abstract: Objective To assess the status of blood pressure control and the utilization of antihypertensive agents among community-dwelling hypertensive individuals, thereby providing a scientific rationale for refining hypertension management strategies. Methods Hypertensive patients who underwent registration and comprehensive physical examinations at a community health service center in Foshan City between January 1 and December 31, 2023, were enrolled as study participants. The analysis focused on blood pressure control outcomes and antihypertensive medication usage across diverse demographic and clinical subgroups, with an exploration of pertinent influencing factors. Results A total of 6 753 patients with a mean age of (68.58±10.30) years were included, and the compliance rate of blood pressure control was 77.54% (5 236/6 753). Multifactorial analysis showed that 60-75 years (OR=2.384),>75 years (OR=2.427), comorbid diabetes mellitus (OR=13.227), and alcohol consumption (OR=1.233) were risk factors for blood pressure control(P<0.05 or P<0.01). Regarding pharmacological treatment, 31.81% (2 148 cases) of patients received monotherapy and 68.19% (4 605 cases) received combination therapy. The most used drugs in monotherapy were angiotensin receptor blockers (63.18%, 1 357 cases), while angiotensin receptor blockers combined with calcium channel blocker regimens were predominant in combination therapy (34.38%, 1 583 cases). In addition, a lower proportion of women (OR=0.836) received combination therapy, while a higher proportion of overweight (OR=1.215), obese (OR=1.639), and current smokers (OR=1.507) received combination therapy(P<0.05 or P<0.01). Conclusions The hypertension control rate within this community is notably high. It is advocated to implement targeted intervention measures addressing pivotal influential factors to further elevate the efficacy of blood pressure management. Simultaneously, considering most patients are on combination therapy, it is recommended to refine medication selection based on individual patient clinical characteristics to ensure therapeutic safety and efficacy.

Key words: Hypertension, Blood pressure control, Antihypertensive agents, Combination therapy

CLC Number: 

  • R183.3